Meta-analysis of efficacy and adverse events of erlotinib-based targeted therapies for advanced/metastatic non-small cell lung cancer. [electronic resource]
Publication details: Oncotarget Oct 2017Description: 86816-86827 p. digitalISSN:- 1949-2553
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.